In connection with tomorrow's Annual General Meeting (the "AGM)") in Nykode
Therapeutics ASA (the "Company"), the Company's Chair of the Board, Martin
Nicklasson, has received open proxies to represent a total of 20,903,819 shares
in the Company at the AGM, corresponding to 7.07% of the total number of votes
and shares in the Company. The proxies are only valid for the AGM and will lapse
thereafter. Together with the 32,000 shares held by Martin Nicklasson, he will
represent a total of 20,935,819 votes at the AGM, corresponding to a total of
7.09% of the total number of shares and votes in the Company.

Martin Nicklasson also holds a total of 500,000 unexercised options to subscribe
for one share each in the Company. Assuming vesting and exercise of all options,
this represents a total of 21,435,819 number of shares and votes in the company
when adding this to the open proxies and shares held, equal to 7.25% of the
current issued registered share capital in the Company, i.e. without taking into
account the dilutive effect of any option exercises in the denominator.